• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Testing and estimation of time-varying cause-specific hazard ratios with covariate adjustment.具有协变量调整的时变特定病因风险比的检验与估计。
Biometrics. 2008 Dec;64(4):1070-9. doi: 10.1111/j.1541-0420.2008.01012.x. Epub 2008 Mar 19.
2
Comparison of competing risks failure time methods and time-independent methods for assessing strain variations in vaccine protection.比较用于评估疫苗保护中应变变异的竞争风险失败时间方法和与时间无关的方法。
Stat Med. 2000 Nov 30;19(22):3065-86. doi: 10.1002/1097-0258(20001130)19:22<3065::aid-sim600>3.0.co;2-d.
3
Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacy.具有多变量连续标记的标记特异性风险比模型:在疫苗效力中的应用
Biometrics. 2013 Jun;69(2):328-37. doi: 10.1111/biom.12016. Epub 2013 Feb 19.
4
Sieve analysis: methods for assessing from vaccine trial data how vaccine efficacy varies with genotypic and phenotypic pathogen variation.筛析:从疫苗试验数据评估疫苗效力如何随基因型和表型病原体变异而变化的方法。
J Clin Epidemiol. 2001 Jan;54(1):68-85. doi: 10.1016/s0895-4356(00)00258-4.
5
Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines.存在疫苗效力衰减情况下的疫苗效力评估:在霍乱疫苗中的应用
Am J Epidemiol. 1998 May 15;147(10):948-59. doi: 10.1093/oxfordjournals.aje.a009385.
6
The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy.基于连续标记的失效率的双样本问题:在疫苗效力中的应用。
Biostatistics. 2008 Apr;9(2):263-76. doi: 10.1093/biostatistics/kxm028. Epub 2007 Aug 17.
7
PROPORTIONAL HAZARDS MODELS WITH CONTINUOUS MARKS.具有连续标记的比例风险模型
Ann Stat. 2009 Feb 1;37(1):394-426. doi: 10.1214/07-AOS554.
8
Mark-specific proportional hazards model with multivariate continuous marks and its application to HIV vaccine efficacy trials.带有多元连续标记的标记特异性比例风险模型及其在 HIV 疫苗功效试验中的应用。
Biostatistics. 2013 Jan;14(1):60-74. doi: 10.1093/biostatistics/kxs022. Epub 2012 Jul 3.
9
Weighted likelihood method for grouped survival data in case-cohort studies with application to HIV vaccine trials.病例队列研究中分组生存数据的加权似然法及其在HIV疫苗试验中的应用
Biometrics. 2008 Dec;64(4):1247-55. doi: 10.1111/j.1541-0420.2008.00998.x.
10
Estimation of vaccine efficacy for variants that emerge after the placebo group is vaccinated.估计在安慰剂组接种疫苗后出现的变异株的疫苗效力。
Stat Med. 2022 Jul 20;41(16):3076-3089. doi: 10.1002/sim.9405. Epub 2022 Apr 8.

引用本文的文献

1
Analysis of the time-varying Cox model for the cause-specific hazard functions with missing causes.分析具有缺失原因的特定原因危害函数的时变 Cox 模型。
Lifetime Data Anal. 2020 Oct;26(4):731-760. doi: 10.1007/s10985-020-09497-y. Epub 2020 Apr 9.
2
Applying competing risks regression models: an overview.应用竞争风险回归模型:概述
Lifetime Data Anal. 2013 Jan;19(1):33-58. doi: 10.1007/s10985-012-9230-8. Epub 2012 Sep 26.

本文引用的文献

1
Pathogenic epitopes, heterologous immunity and vaccine design.致病表位、异源免疫与疫苗设计。
Nat Rev Microbiol. 2007 Jul;5(7):555-63. doi: 10.1038/nrmicro1709.
2
Influenza vaccine--outmaneuvering antigenic shift and drift.流感疫苗——应对抗原转变与抗原漂移
N Engl J Med. 2004 Jan 15;350(3):218-20. doi: 10.1056/NEJMp038238.
3
Poliovirus vaccine options.脊髓灰质炎疫苗的选择。
Am Fam Physician. 1999 Jan 1;59(1):113-8, 125-6.
4
Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines.存在疫苗效力衰减情况下的疫苗效力评估:在霍乱疫苗中的应用
Am J Epidemiol. 1998 May 15;147(10):948-59. doi: 10.1093/oxfordjournals.aje.a009385.
5
Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade.抗体、巨噬细胞、登革病毒感染、休克与出血:一种发病机制级联反应。
Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S830-9. doi: 10.1093/clinids/11.supplement_4.s830.
6
Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up.孟加拉国口服霍乱疫苗现场试验:三年随访结果
Lancet. 1990 Feb 3;335(8684):270-3. doi: 10.1016/0140-6736(90)90080-o.
7
The analysis of failure times in the presence of competing risks.存在竞争风险时的失效时间分析。
Biometrics. 1978 Dec;34(4):541-54.

具有协变量调整的时变特定病因风险比的检验与估计。

Testing and estimation of time-varying cause-specific hazard ratios with covariate adjustment.

作者信息

Sun Yanqing, Hyun Seunggeun, Gilbert Peter

机构信息

Department of Mathematics and Statistics, University of North Carolina at Charlotte, Charlotte, North Carolina 28223, USA.

出版信息

Biometrics. 2008 Dec;64(4):1070-9. doi: 10.1111/j.1541-0420.2008.01012.x. Epub 2008 Mar 19.

DOI:10.1111/j.1541-0420.2008.01012.x
PMID:18355384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9841889/
Abstract

In the evaluation of efficacy of a vaccine to protect against disease caused by a genetically diverse infectious pathogen, it is often important to assess whether vaccine protection depends on variations of the exposing pathogen. This problem can be viewed within the framework of a K-competing risks model where the endpoint event is pathogen-specific infection and the cause of failure is the strain type determined after the infection is diagnosed. The Cox model with time-dependent coefficients is used to relate the cause-specific outcomes to explanatory variables to allow for time-varying treatment effects. The strain-specific vaccine efficacy can be defined in terms of one minus the cause-specific hazard ratios. We develop inferential methods for testing whether the vaccine affords some protection against at least one pathogen strain, and for testing equal vaccine protection against the strains, adjusting for covariate effects. We also consider estimation of covariate-adjusted time-varying strain-specific vaccine efficacy. The methods are applied to a dataset from an oral cholera vaccine trial and the performances of the proposed tests are studied through simulations. These techniques apply more generally for testing and estimation of time-varying cause-specific hazard ratios.

摘要

在评估一种疫苗预防由基因多样化的传染性病原体引起的疾病的效力时,评估疫苗保护是否取决于暴露病原体的变异通常很重要。这个问题可以在一个K竞争风险模型的框架内看待,其中终点事件是病原体特异性感染,失败原因是感染被诊断后确定的菌株类型。具有时间依赖系数的Cox模型用于将病因特异性结局与解释变量相关联,以考虑随时间变化的治疗效果。菌株特异性疫苗效力可以用1减去病因特异性风险比来定义。我们开发了推断方法,用于检验疫苗是否对至少一种病原体菌株提供了一定的保护,以及检验对各菌株的疫苗保护是否相等,并对协变量效应进行调整。我们还考虑了协变量调整后的随时间变化的菌株特异性疫苗效力的估计。这些方法应用于一项口服霍乱疫苗试验的数据集,并通过模拟研究了所提出检验的性能。这些技术更广泛地应用于随时间变化的病因特异性风险比的检验和估计。